Next Article in Journal
Design, Synthesis, Characterization, and Evaluation of the Anti-HT-29 Colorectal Cell Line Activity of Novel 8-Oxyquinolinate-Platinum(II)-Loaded Nanostructured Lipid Carriers Targeted with Riboflavin
Next Article in Special Issue
Developing a Formulation Strategy Coupled with PBPK Modeling and Simulation for the Weakly Basic Drug Albendazole
Previous Article in Journal
Carbon Dots: Opportunities and Challenges in Cancer Therapy
Previous Article in Special Issue
Interplay of Breast Cancer Resistance Protein (Bcrp/Abcg2), Sex, and Fed State in Oral Pharmacokinetic Variability of Furosemide in Rats
 
 
Article

Article Versions Notes

Pharmaceutics 2023, 15(3), 1020; https://doi.org/10.3390/pharmaceutics15031020
Action Date Notes Link
article xml file uploaded 22 March 2023 08:37 CET Original file -
article xml uploaded. 22 March 2023 08:37 CET Update -
article pdf uploaded. 22 March 2023 08:37 CET Version of Record https://www.mdpi.com/1999-4923/15/3/1020/pdf-vor
article supplementary file uploaded. 22 March 2023 08:37 CET - https://www.mdpi.com/1999-4923/15/3/1020#supplementary
article html file updated 22 March 2023 08:38 CET Original file -
article xml file uploaded 23 March 2023 07:08 CET Update -
article xml uploaded. 23 March 2023 07:08 CET Update https://www.mdpi.com/1999-4923/15/3/1020/xml
article pdf uploaded. 23 March 2023 07:08 CET Updated version of record https://www.mdpi.com/1999-4923/15/3/1020/pdf
article html file updated 23 March 2023 07:09 CET Update -
article html file updated 6 April 2023 21:34 CEST Update https://www.mdpi.com/1999-4923/15/3/1020/html
Back to TopTop